PRIMARY RESEARCH | PUBMED LINKS
DRUG CATEGORY: HORMONES FOR MEN
DRUG NAME: TESTOSTERONE CYPIONATE

  • FDA Safety Data Sheet can be found here

  • Bhasin S. Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study. Am Heart J. 2022 [PubMed Link]

  • Greenberg DR. Association of testosterone replacement therapy with atrial fibrillation and acute kidney injury. J Sex Med. 2024 [PubMed Link]

  • Corona G. Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opin Drug Saf. 2014 [PubMed Link] 

  • Lombardi G. Estrogens and health in males. Mol Cell Endocrinol. 2001 [PubMed Link] 

  • Bhasin S. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018 [PubMed Link]

  • Winters SJ. Current status of testosterone replacement therapy in men. Arch Fam Med. 1999 [PubMed Link]

  • Borst SE. Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis. BMC Med. 2014 [PubMed Link]

  • Hoffman BM. Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men. Int J Impot Res. 2010 [PubMed Link] 

  • Sharma R. Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. Eur Heart J. 2015 [PubMed Link]

  • Finkelstein JS. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013 [PubMed Link]

  • Khera M. Adult-Onset Hypogonadism. Mayo Clin Proc. 2016 [PubMed Link]

  • Mlynarz N. Effects of Testosterone Replacement Therapy on Metabolic Syndrome in Male Patients-Systematic Review. Int J Mol Sci. 2024 [PubMed Link]

  • Mahmoud M. The Effects of Testosterone Replacement Therapy in Adult Men With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-analysis. Clin Transl Gastroenterol. 2025 [PubMed Link]

  • Grossmann M. Indications for testosterone therapy in men. Curr Opin Endocrinol Diabetes Obes. 2024 [PubMed Link]

  • Dengri C. Testosterone supplementation and stroke in young adults: a review of the literature. Front Neurol. 2024 [PubMed Link]

  • Cruickshank M. The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation. Health Technol Assess. 2024 [PubMed Link]

  • de Silva NL. Cardiovascular disease and testosterone therapy in male hypogonadism. Ann N Y Acad Sci. 2024 [PubMed Link]

  • De Silva NL. Male hypogonadism: pathogenesis, diagnosis, and management. Lancet Diabetes Endocrinol. 2024 [PubMed Link]

  • Theodorakis N. Testosterone therapy for functional hypogonadism in middle-aged and elderly males: current evidence and future perspectives. Hormones (Athens). 2024 [PubMed Link]

  • Gallegos JL. Testosterone replacement therapy for hypogonadism: A primer for primary care. Nurse Pract. 2024 [PubMed Link

  • Pencina KM. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism. J Clin Endocrinol Metab. 2024 [PubMed Link]